Abstract
Uveal melanoma is the most common primary malignancy of the eye, and a number of discoveries in the last decade have led to a more thorough molecular characterization of this cancer. However, the prognosis remains dismal for patients with metastases, and there is an urgent need to identify treatments that are effective for this stage of disease. Animal models are important tools for preclinical studies of uveal melanoma. A variety of models exist, and they have specific advantages, disadvantages, and applications. In this review article, these differences are explored in detail, and ideas for new models that might overcome current challenges are proposed.
Original language | English (US) |
---|---|
Pages (from-to) | 264-278 |
Number of pages | 15 |
Journal | Pigment Cell and Melanoma Research |
Volume | 33 |
Issue number | 2 |
DOIs | |
State | Published - Mar 1 2020 |
Externally published | Yes |
Keywords
- melanoma
- mouse
- transgenic mouse
- uveal
- xenograft
ASJC Scopus subject areas
- General Biochemistry, Genetics and Molecular Biology
- Dermatology
- Oncology